NEA Management Company’s Black Diamond Therapeutics BDTX Stock Holding History

NEA Management Company’s Portfolio BDTX Stock Details BDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.23M	Hold	4,448,757	–	–	0.52%	18
2026 Q1	$9.48M	Hold	4,448,757	–	–	0.54%	18
2025 Q4	$10.8M	Hold	4,448,757	–	–	0.55%	18
2025 Q3	$16.9M	Hold	4,448,757	–	–	0.93%	18
2025 Q2	$11M	Hold	4,448,757	–	–	0.83%	20
2025 Q1	$6.9M	Hold	4,448,757	–	–	0.53%	24
2024 Q4	$9.52M	Hold	4,448,757	–	–	0.54%	26
2024 Q3	$19.4M	Hold	4,448,757	–	–	1.05%	17
2024 Q2	$20.7M	Hold	4,448,757	–	–	1.56%	15
2024 Q1	$22.6M	Hold	4,448,757	–	–	1.4%	16
2023 Q4	$12.5M	Hold	4,448,757	–	–	0.83%	24
2023 Q3	$12.8M	Hold	4,448,757	–	–	0.99%	24
2023 Q2	$22.5M	Buy	4,448,757 +1,000,000	+29%	+$2.04M	1.72%	20
2023 Q1	$6.52M	Hold	3,448,757	–	–	0.45%	32
2022 Q4	$6.21M	Sell	3,448,757 -1,088	-0%	-$1.96K	0.35%	36
2022 Q3	$5.83M	Hold	3,449,845	–	–	0.29%	40
2022 Q2	$8.49M	Hold	3,449,845	–	–	0.44%	36
2022 Q1	$9.56M	Hold	3,449,845	–	–	0.28%	43
2021 Q4	$18.4M	Hold	3,449,845	–	–	0.37%	32
2021 Q3	$29.2M	Hold	3,449,845	–	–	0.35%	27
2021 Q2	$42.1M	Hold	3,449,845	–	–	0.55%	27
2021 Q1	$83.7M	Hold	3,449,845	–	–	1.88%	15
2020 Q4	$111M	Hold	3,449,845	–	–	2.92%	11
2020 Q3	$104M	Hold	3,449,845	–	–	4.42%	8
2020 Q2	$145M	Hold	3,449,845	–	–	5.85%	8
2020 Q1	$86.1M	Buy	+3,449,845	New	+$105M	4.5%	8

Other funds holding BDTX

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

DCM

Defilade Capital Management Emeryville, California $747M AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $52.8B AUM 58.98% 1-Year Est. Return

AIC

AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return

NEA Management Company's BDTX Position: Q2 2026 in Review

NEA Management Company held its Black Diamond Therapeutics (BDTX) position steady in Q2 2026 at 4,448,757 shares worth $8.23M. The position accounts for 0.52% of the portfolio, ranked #18.

NEA Management Company first reported a position in BDTX in Q1 2020 and has held it in 26 quarters since. The position peaked at $145M in Q2 2020. 96 funds tracked by Wall St. Rank hold BDTX as of Q2 2026.

NEA Management Company held 4,448,757 shares of Black Diamond Therapeutics worth $8.23M as of Q2 2026.
NEA Management Company left its Black Diamond Therapeutics share count unchanged in Q2 2026.
Black Diamond Therapeutics made up 0.52% of NEA Management Company's portfolio in Q2 2026, its #18 holding.
NEA Management Company first reported a position in Black Diamond Therapeutics in Q1 2020 and has held it in 26 quarters since.
NEA Management Company's Black Diamond Therapeutics position peaked at $145M in Q2 2020.
96 funds tracked by Wall St. Rank held Black Diamond Therapeutics as of Q2 2026.

Based on NEA Management Company's 13F filing for Q2 2026, filed 14 Aug 2026.